NEW YORK — Pfizer said Tuesday it will cut 6,000 jobs as it trims manufacturing capacity for health care products worldwide after acquiring smaller rival Wyeth last year. The world’s biggest drugmaker and producer of Viagra says it will cease operations at eight plants in Ireland, Puerto Rico and the U.S. by the end of 2015 and reduce operations at six other plants over the next several years.
The New York-based company said in April it would cut 20,000 jobs as it integrates Wyeth, which it bought in October for $68 billion.
Pfizer, which also sells the cholesterol drug Lipitor, gained an assortment of products from Wyeth, including the biotech drug Enbrel for rheumatoid arthritis and menopause treatments Premarin and Prempro.
The Associated Press
